Source: Eur Respir Rev, 27 (148) 180035; 10.1183/16000617.0035-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Alberto Matteelli, Adrian Rendon, Simon Tiberi, Seif Al-Abri, Constantia Voniatis, Anna Cristina C. Carvalho, Rosella Centis, Lia D'Ambrosio, Dina Visca, Antonio Spanevello, Giovanni Battista Migliori. Tuberculosis elimination: where are we now?. Eur Respir Rev, 27 (148) 180035; 10.1183/16000617.0035-2018

Member's Comments

No comment yet.

Related content which might interest you: Tuberculosis elimination: dream or reality? The case of Cyprus Source: Eur Respir J 2014; 44: 543-546 Year: 2014 Tuberculosis: are we making it incurable? Source: Eur Respir J 2013; 42: 5-8 Year: 2013 Tuberculosis elimination: a dream or a reality? The case of Oman Source: Eur Respir J, 51 (1) 1702027; 10.1183/13993003.02027-2017 Year: 2018 Tuberculosis situation and control in Europe: where are we and what to do next? Source: Eur Respir J 2005; 26: Suppl. 49, 476s Year: 2005 Perinatal tuberculosis: A forgotten disease? Source: International Congress 2016 – Paediatric respiratory infections Year: 2016 Is it necessary to give tuberculosis treatment daily throughout? Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 Lymphocytopenia in pulmonary tuberculosis: Does it have a clinical value? Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016 Tuberculosis elimination: theory and practice in Europe Source: Eur Respir J 2014; 43: 1410-1420 Year: 2014 Tuberculosis of the immunocompromised: what particularities? Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Tuberculosis: clinical scenario Source: ERS Course 2018 - Respiratory Infections Year: 2018 Tuberculosis elimination in Oman: winning the war on the disease Source: ERJ Open Res, 4 (4) 00121-2018; 10.1183/23120541.00121-2018 Year: 2018 Statin use and the risk of tuberculosis: Data from 305,142 patients Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology Year: 2016 The European union standards for tuberculosis care: Do they need an update? Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 Features of pulmonary tuberculosis in migrants Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015 The particularities of new cases of tuberculosis at homeless people Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Is there a need for prolonged follow up in mono-drug resistant TB? Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Latent TB: what's next? Source: Annual Congress 2007 - Latent tuberculosis: what's next? Year: 2007 Tuberculosis patients: what do they know about their disease Source: Annual Congress 2003 - Clinical aspects of tuberculosis Year: 2003 Detection of tuberculosis in children Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Is the general population well informed about tuberculosis? Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014